Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 884.73 Million | 863.09 Million | 1.13 Billion | 1.19 Billion | 1.15 Billion | 876.93 Million |
| Net Income | 1.16 Billion | 1.58 Billion | 1.3 Billion | 930.32 Million | 809.64 Million | 838.92 Million |
| Depreciation & Amortization | 207.09 Million | 151.16 Million | 143.65 Million | 154.53 Million | 152.79 Million | 171.95 Million |
| Deferred income taxes | 7.54 Million | 3.72 Million | -4.71 Million | 168.42 Thousand | -1.34 Million | 2.77 Million |
| Stock-based compensation | -16.76 Million | 34.06 Million | 47.69 Million | 3.53 Million | - | - |
| Change in working capital | -449.46 Million | 72.56 Million | -48.37 Million | 82.65 Million | 96.77 Million | -34.72 Million |
| Other non-cash items | 815.38 Million | -980.25 Million | -312.3 Million | 21.07 Million | 92.95 Million | -99.21 Million |
| Investing Cash Flow | -345.21 Million | 343.99 Million | 34.05 Million | -616.6 Million | -152.49 Million | -749.7 Million |
| Investments in PPE | -348.12 Million | -491.62 Million | -600.74 Million | -479.59 Million | -293.13 Million | -773.06 Million |
| Acquisitions | 415.51 Thousand | -0.14 | 20.37 Million | -28.13 Million | 24.01 Thousand | 778.43 Million |
| Investment purchases | -238.1 Million | -1.15 Billion | -844.5 Million | -510 Million | -438 Million | -518 Million |
| Sales/Maturities of investments | 240.6 Million | 1.99 Billion | 1.45 Billion | 399.93 Million | 579.05 Million | 535.99 Million |
| Other Investing Activities | 26.13 Million | -3.65 Million | 0.63 | 1.18 Million | -446.43 Thousand | -773.06 Million |
| Financing Cash Flow | -223.95 Million | -1.28 Billion | -695.59 Million | -480.78 Million | -954.19 Million | -207.69 Million |
| Debt repayment | -150 Million | - | - | -400 Million | -851.31 Million | -501.31 Million |
| Dividends payments | -495.93 Million | -1.09 Billion | -425.03 Million | -403.57 Million | -406.79 Million | -355.7 Million |
| Common Stock Repurchased | - | - | - | -59.41 Million | - | - |
| Common Stock Issuance | - | - | 77.43 Million | 59.41 Million | - | - |
| Other Financing Activities | 421.98 Million | -188.28 Million | -347.99 Million | 332.96 Million | 324.46 Million | 649.32 Million |
| Accounts receivables | -430.92 Million | 140.56 Million | -97.73 Million | 2.33 Million | -43.13 Million | -68.15 Million |
| Accounts payables | 36.98 Million | 52.92 Million | 57.48 Million | -17.12 Million | -128.49 Million | -42.99 Million |
| Inventory | -55.52 Million | -124.65 Million | -3.41 Million | 97.28 Million | 269.74 Million | 73.65 Million |
| Other working capital | 44.53 Million | 3.72 Million | -4.71 Million | 168.42 Thousand | -1.34 Million | -108.37 Million |
| Cash at beginning of period | 788.06 Million | 865.03 Million | 392.03 Million | 297.13 Million | 251.66 Million | 332.13 Million |
| Cash at end of period | 1.1 Billion | 788.06 Million | 865.03 Million | 392.03 Million | 297.13 Million | 251.66 Million |
| Capital Expenditure | -348.12 Million | -491.62 Million | -600.74 Million | -479.59 Million | -293.13 Million | -773.06 Million |
| Effect of forex changes on cash | 565.74 Thousand | 30.64 | -7.77 | -23.47 | 3.06 | 27.29 |
| Net cash flow / Change in cash | 316.14 Million | -76.97 Million | 473 Million | 94.89 Million | 45.47 Million | -80.46 Million |
| Free Cash Flow | 536.61 Million | 371.46 Million | 533.8 Million | 712.69 Million | 859.03 Million | 103.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 164.11 Million | -445.16 Million | 214.67 Million | 407.68 Million | 1.16 Billion | 275.35 Million |
| Depreciation & Amortization | - | 48.64 Million | 48.64 Million | 53.25 Million | 207.09 Million | -77.2 Million |
| Deferred income taxes | - | - | - | 503.21 Million | 7.54 Million | -190.16 Million |
| Stock-based compensation | - | - | - | -16.76 Million | -16.76 Million | -8.32 Million |
| Change in working capital | - | - | - | -486.45 Million | -449.46 Million | 269.95 Million |
| Other non-cash items | -61.7 Million | 495.98 Million | -60.9 Million | -70.18 Million | 815.38 Million | -118.69 Million |
| Investing Cash Flow | -120.61 Million | -222.22 Million | -139.93 Million | -69.23 Million | -345.21 Million | -86.72 Million |
| Investments in PPE | -187.67 Million | -187.44 Million | -94.71 Million | -69.15 Million | -348.12 Million | -88.97 Million |
| Acquisitions | 66.59 Million | - | - | 415.51 Thousand | 415.51 Thousand | 0.57 |
| Investment purchases | -20 Million | -100 Million | -75 Million | -89.6 Million | -238.1 Million | -36.5 Million |
| Sales/Maturities of investments | 20.47 Million | 65 Million | 30 Million | 89.1 Million | 240.6 Million | 38.74 Million |
| Other Investing Activities | 66.59 Million | 216.97 Thousand | -216.97 Thousand | 2.32 Million | 26.13 Million | - |
| Financing Cash Flow | -121.52 Million | -375.88 Million | -45.04 Million | 119.78 Million | -223.95 Million | 79.98 Million |
| Debt repayment | -133.74 Million | -120.35 Million | -80 Million | - | -150 Million | -80 Million |
| Dividends payments | -495.43 Million | -495.43 Million | -1.01 Million | -495.93 Million | -495.93 Million | -495.93 Million |
| Common Stock Repurchased | 10 Thousand | -10 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -251.96 Million | -798.14 Thousand | -125.04 Million | 615.72 Million | 421.98 Million | 655.91 Million |
| Accounts receivables | - | - | - | -430.92 Million | -430.92 Million | 213.46 Million |
| Accounts payables | - | - | - | - | 36.98 Million | - |
| Inventory | - | - | - | -55.52 Million | -55.52 Million | 56.48 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 477.39 Million | 1.07 Billion | 1.1 Billion | 662.33 Million | 788.06 Million | 518.16 Million |
| Cash at end of period | 332.82 Million | 477.39 Million | 1.07 Billion | 1.1 Billion | 1.1 Billion | 662.33 Million |
| Capital Expenditure | -187.67 Million | -187.44 Million | -94.71 Million | -69.15 Million | -348.12 Million | -88.97 Million |
| Effect of forex changes on cash | 917.85 | 59.72 Thousand | 283.52 Thousand | 565.73 Thousand | 565.74 Thousand | -2.33 |
| Net cash flow / Change in cash | -144.57 Million | -595.87 Million | -30.92 Million | 441.87 Million | 316.14 Million | 144.16 Million |
| Free Cash Flow | -85.26 Million | -185.26 Million | 59.04 Million | 321.6 Million | 536.61 Million | 61.93 Million |
8076
YIPS
STMEF
601198
600638
LAES